NEUMANN CLARKE 4
4 · BIORA THERAPEUTICS, INC. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Neumann Clarke
General Counsel and Secretary
Transactions
- Award
Common Stock
2023-03-15+57,950→ 79,568 total - Award
Common Stock
2023-03-15+21,684→ 101,252 total - Tax Payment
Common Stock
2023-03-15$2.56/sh−10,683$27,348→ 90,569 total
Footnotes (3)
- [F1]Consists of 57,950 restricted stock units ("RSUs"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer.
- [F2]Consists of 21,684 RSUs, which vested upon grant.
- [F3]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.